GlassScriptPhysician profile
Jincy Sajan
NPI 1710644851
$5,591.76
in general payments reported to CMS, 2019-2025
35 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,594 · 2024: $2,611 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,821 · Food and Beverage: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,820.65 |
| Food and Beverage | $1,176.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals As | $1,251.36 | 2024 | Adstiladrin |
| Merck Sharp & Dohme LLC | $1,174.44 | 2022-2024 | |
| Seagen INC. | $346.72 | 2022 | |
| Amgen INC. | $337.64 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $241.04 | 2022 | |
| Janssen Scientific Affairs, LLC | $222.17 | 2022 | |
| Lilly USA, LLC | $209.32 | 2022 | |
| Incyte Corporation | $171.17 | 2022 | |
| Sumitomo Pharma America, INC. | $166.89 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $154.07 | 2022-2025 | Erleada |
| Cti Biopharma Corp. | $136.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $120.15 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $119.74 | 2022 | |
| Novo Nordisk INC | $115.26 | 2024 | Rivfloza |
| Rigel Pharmaceuticals, INC. | $92.45 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $90.19 | 2024-2025 | Gentlecath |
| Pharmacyclics LLC, An Abbvie Company | $81.59 | 2022 | |
| Glaxosmithkline, LLC. | $76.53 | 2022 | |
| Celgene Corporation | $71.52 | 2022 | |
| Abbvie INC. | $49.80 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $39.98 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.70 | 2022 | |
| Pfizer INC. | $29.19 | 2025 | |
| Daiichi Sankyo INC. | $28.80 | 2022 | |
| Procept Biorobotics Corporation | $26.56 | 2025 | |
| Laborie Medical Technologies Corp. | $24.97 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Eisai INC. | $24.56 | 2022 | |
| Deciphera Pharmaceuticals INC. | $24.05 | 2022 | |
| Kyowa Kirin, INC. | $23.80 | 2022 | |
| Morphosys, US INC. | $22.03 | 2022 | |
| Stemline Therapeutics INC. | $19.30 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.54 | 2025 | Exparel |
| Taiho Oncology, INC. | $18.41 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.55 | 2022 | |
| Astellas Pharma US INC | $15.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jincy Sajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.